ARCHIVES

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

Bypass Budget Omits Needless Words: Faster Progress to Cost $421 Million More

March 29, 1996

“You Can’t Legislate Biology,” Higginson Tells AACI Members

February 9, 1979

President, Congress Decry Practice Of “Drive-Through Mastectomies

February 21, 1997

MEPACT Approved In Europe For Resectable Osteosarcoma

March 27, 2009

BSA Working Group

November 12, 2010

In Congress: Varmus Defends Raise In Cancer Funding; Porter Says Allocation Difficult If No Agreement On Tobacco Legislation

March 13, 1998